After the Bell CTIX PR: "In a blatant and rather

After the Bell CTIX PR:

"In a blatant and rather self-serving effort to prop up our current stock price, Cellceutix is pleased to announce . . .  nothing! Since getting our investors truly excited and overly pumped up regarding the events at ASCO . . . only to utterly flop . . . We have decided to take another strategic path following in the steps of New England Patriots coach Bill Belichick and say nothing more regarding Kevetrin and Prurisol until the clinical trial results are in", noted CEO Leo Ehrlich. "The way CTIX is falling, we may be trading at near zero by the time Prurisol results are released", said Ehrlich. "Dr Menon and my personal net worth is down 30 percent since ASCO, and frankly, we need to do something before you see us on the street corner holding signs, Will work for funds to complete clinical trials."

"We expect the results for our breakthrough treatments Kevetrin and Prurisol to rival those of all major pharma's . . . Clovis, Pharmacyclics, Celgene, J&J, etc." commented Dr. Menon. We plan on helping a lot of people and making a ton of money, but we can't accomplish this with "lame-o" press releases, I have been telling this to Leo for months, and now he is finally listening." Like someone once said, your best offense is a good defense . . . Cellceutix is now going defensive, like "Mean Joe Green" on an all out quarterback blitz, said Ehrlich. "From this point forward, investors will be informed on a "need to know" basis, including all those "nut-jobs" on IHub who contract me daily like I have absolutely nothing better to do with my time then to reply to those losers, while I am trying to build a pharmaceutical empire", commented Ehrlich.

"Like I have always said, the best is yet to come for CTIX!"

LEO